The LITE Study

Home Phototherapy is Comparable to Office Phototherapy

The LITE study demonstrated that home phototherapy is non-inferior to office phototherapy, with excellent effectiveness and safety.

Did You Know?

What is Phototherapy?

Phototherapy, or light therapy, involves exposing the skin to ultraviolet light on a regular basis as prescribed by a health care provider. Treatments can be done in a health care provider's office or at home with a phototherapy unit.

Major barriers affect the ability to access phototherapy in the dermatologist’s office, including limited geographic availability, the inconvenience of attending regular appointments for treatment, and high copays. Home phototherapy is available, but health insurance companies are less likely to cover this treatment option, and health care providers may be uncertain about prescribing it.

What is the LITE Study?

Conducted from 2019 to 2023, the Light Treatment Effectiveness or LITE study was a large pragmatic randomized study embedded in routine clinical practice. The study was the result of a collaboration between the National Psoriasis Foundation (NPF), the University of Pennsylvania Perelman School of Medicine, and the University of Utah. The LITE study was funded by the Patient Centered Outcomes Research Institute (PCORI), an independent research institute authorized by Congress in 2010 that funds comparative clinical effectiveness research that engages patients and other stakeholders throughout the research process.

An icon of a target with an arrow in the center.

Aim

The LITE study aimed to compare the effectiveness, safety (tolerability), and duration of treatment response at 12 weeks of home versus office-based narrowband ultraviolet B phototherapy for the treatment of plaque or guttate psoriasis across all skin types.

An icon of a group of three people.

Population

The LITE study enrolled people ages 12 and older with plaque or guttate psoriasis who were candidates for phototherapy. The study was representative of a variety of skin types ranging from people with very fair skin to people with very darkly pigmented skin.

Icon illustration of a light bulb.

Comparisons

The LITE study compared home-based phototherapy and clinic-based phototherapy for effectiveness, safety, and duration of treatment response. The study also examined whether skin color affects the effectiveness of phototherapy.

icon of an open magazine

Findings

The LITE study demonstrated that home phototherapy is non-inferior to office phototherapy, with both home and office phototherapy demonstrating excellent effectiveness and safety in real-world settings across all skin types. The findings support the use of home phototherapy as a first-line treatment option for psoriasis, including individuals with no prior phototherapy experience, and advocates for efforts to make phototherapy more available to people living with psoriasis.

Patient Testimonials

Alisha Bridges lives with psoriasis and served on the LITE study patient stakeholder committee.

Eric Fielding has lived with psoriasis since 1993 and was a member of the LITE study patient stakeholder committee.

Additional Resources

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity Navigator

Copyright © 1996-2025 National Psoriasis Foundation/USA


The National Psoriasis Foundation is a qualified 501(c)(3) EIN 93-0571472.


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.